Benefit Risk Assessment
Benefit Risk Assessment - Related Videos
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
0 Views •
Cited by 40 •
2014
The NICU Network Neurobehavioral Scale (NNNS) was developed as an assessment for the at-risk infant. The purpose of this article is to describe the NNNS, provide video examples of the NNNS procedures and discuss the ways in which the exam has been used.
05:59
The Costs and Benefits of Natural Pedagogy
0 Views •
2023
Source: Laboratories of Nicholaus Noles, Judith Danovitch, and Asheley Landrum—University of Louisville Children have many tools they use over the course of development to learn from adults. Perhaps the earliest tool is imitation, simply copying what they see an adult do or say. However, children actually learn much more effectively than one might expect if they were only imitating. This is because, when it comes to learning and teaching, children and adults have a special relationship.
01:25
Benefits of Self-Esteem
0 Views •
2025
Self-esteem—an individual's overall evaluation of their worth—plays a complex role in psychological functioning and well-being. It is often associated with many positive traits, such as confidence, optimism, and perseverance. Individuals with high self-esteem typically experience better sleep, manage peer pressure more effectively, and report greater life satisfaction. Conversely, low self-esteem has been consistently linked with increased risks of depression, anxiety, and poor academic or...
01:25
Social Cost and Benefit
0 Views •
2025
External marginal costs are additional costs imposed on third parties when one more unit of a good or service is produced or consumed. These costs are not borne by the producer or consumer but by others outside the market exchange. External marginal benefits are additional benefits received by third parties when one more unit of a good or service is produced or consumed. These benefits are not received by the producer or consumer but by others outside the market exchange. Social costs include...
07:05
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
0 Views •
Cited by 3 •
2018
A cost-benefit analysis is a weighing-scale approach that the brain performs during the course of decision making. Here, we propose a protocol to train rats on an operant-based decision-making paradigm where rats choose higher rewards at the expense of waiting for 15 s to receive them.
FAQs
Interpretation depends on more than the average treatment effect. An assessment examines treatment benefits and adverse events in relation to a defined patient population and the circumstances of use. The same intervention may therefore present a different balance when disease severity, patient characteristics, or clinical setting changes. This context-specific approach helps decision makers avoid treating risk as an isolated number.
Qualitative approaches describe the relative importance and direction of benefits, risks, and uncertainty, whereas quantitative approaches compare these factors more explicitly. Both approaches organize evidence about treatment effects and adverse events, but they express the trade-offs differently. Selecting either approach, or using both, allows clinical and regulatory decision makers to communicate how evidence supports a particular judgment.
Uncertainty affects how confidently decision makers can interpret observed benefits and risks. Disease severity influences the significance of the expected treatment benefit, while available alternatives provide an important comparison for judging whether the intervention offers meaningful value. Considering these factors prevents the evidence from being interpreted without regard to the seriousness of the condition or the choices already available.
The process starts by defining the patient population and use context, then assembling evidence on treatment effects, adverse events, uncertainty, disease severity, and available alternatives. Decision makers compare these benefit and risk factors using qualitative or quantitative approaches. The resulting judgment can then inform development, authorization, prescribing, or risk management, depending on the decision being considered.
Clinical trials provide evidence during development and evaluation, while real-world data can add information from broader or routine use. Post-market safety monitoring may identify additional safety evidence after an intervention becomes available. Because these sources accumulate at different stages, Benefit Risk Assessment is updated as knowledge changes rather than treated as a permanently fixed conclusion.
The framework supports several decisions across an intervention’s life cycle. Researchers can use it during development, regulators can apply it when considering authorization, and clinicians can consider its conclusions when prescribing. Risk management also relies on the same structured comparison. By making trade-offs more transparent, the approach supports communication among researchers, clinicians, regulators, and patients.